key: cord-0696070-zu8zs91g authors: Holtzman, G. S.; Yang, Y.; Louis, P. title: Did COVID-19 Vaccines Go to the Whitest Neighborhoods First? Racial Inequities in Six Million Phase 1 Doses Shipped to Pennsylvania date: 2022-03-13 journal: nan DOI: 10.1101/2022.03.12.22272300 sha: 22bb37c2afd1f2dec503bf071c3309d5262e6b49 doc_id: 696070 cord_uid: zu8zs91g Research on racial disparities in COVID-19 vaccination rates has focused primarily on vaccine hesitancy. However, vaccine hesitancy research is increasingly unable to account for racial disparities in vaccination rates in the U.S., which have shrunk rapidly over the past year. This and other evidence suggests that inequities in vaccine allocation and access may have contributed to vaccination rate disparities in the U.S. But to our knowledge, no previously published research has examined whether the geographic distribution of COVID-19 vaccines has led to greater access for White Americans than for Black Americans. Here, we link neighborhood-level data on vaccine allocation to data on racial demographics to show that in the first 17 weeks of Pennsylvania's COVID-19 vaccine rollout (Phase 1), White people were 25% more likely than Black people to live in neighborhoods (census tracts) that received vaccine shipments. In the 17 weeks of Pennsylvania's de jure restrictions on vaccine eligibility, de facto geographic restrictions on vaccine access disproportionately disadvantaged Black people and favored White people. In revealing these vaccine inequities, our work builds on prior work to develop a theory-driven, evidence-based, reproducible framework for studying racial inequities in the distribution of COVID-19 vaccines. Racial and ethnic disparities in COVID-19 vaccination rates in the U.S. have been widely discussed in the media and in scientific literature 1, 2 . The dominant narrative is that these disparities are driven by differences in vaccine hesitancy [3] [4] [5] [6] [7] . That explanation is plausible, given the 400-year history of race-based medical atrocities and inequities in (and en route to) the Americas 8, 9 . It is also supported by a great deal of survey research, which has generally found greater COVD-19 vaccine hesitancy among Black and Hispanic/Latino/a/e/x people than White people in the U.S. 1,10-12 . However, there are a number of reasons to believe that this prevailing explanation for vaccination rate disparities in the U.S. is at best incomplete. Racial and ethnic disparities in COVID-19 vaccine hesitancy in the U.S. have declined only slightly in the past year 13, 14 , whereas Black/White disparities in vaccination rates have dropped by over 90% in that time 15, 16 . In at least nine states, including Pennsylvania, Black people are now more likely than White people to have been vaccinated 17 . Nationally, the Hispanic and Latino/a/e/x population has now been vaccinated at higher rates than the non-Hispanic, non-Latino/a/e/x population 15 . Racial disparities in vaccine uptake have been observed in the U.S. even among people who are not hesitant to be vaccinated 13 . In contrast, little or no racial disparity in vaccine uptake has been observed in the U.K., despite racial disparities in vaccine hesitancy in the U.K. similar to those observed in the U.S. 13 . Collectively, these findings suggest that "issues related to access may underlie the observed lower vaccine uptake among minority populations in the U.S." 13 . In that case, new approaches are needed to help understand and overcome the barriers to racial and ethnic equity in COVID-19 vaccine access in the U.S. One effective technique for studying health disparities is to link neighborhood-level data on the availability of scarce resources (like COVID-19 vaccines) to data on racial and ethnic demographics 18 . If demographic differences in health outcomes track geographic differences in health resource availability, racial and ethnic disparities in health outcomes may be remedied by more equitably allocating healthcare resources across neighborhoods. This technique has provided critical insights into a number of complex geodemographic relationships, illuminating some of the hidden causes of Black-White disparities in heart disease (supermarket access) and cancer (air quality) 19, 20 . Here, we draw on this methodology to analyze the relationship between the racial and ethnic populations of 3,218 neighborhoods (defined as census tracts 21 ) and the shipping destinations of 6,365,810 COVID-19 vaccine doses allocated across Pennsylvania. Because our emphasis is the just distribution of scarce medical resources 22-25 , we focus on Phase 1 of Pennsylvania's vaccine distribution plan (December 14, 2020 through April 12, 2021) 26 . During this period, the state prioritized certain groups (e.g., all adults aged 65 or older) as vaccine-eligible in order "to ensure ethical allocation of scarce vaccine" 27 . We chose Pennsylvania because it was the only U.S. state to provide separate datasets for doses allocated by the state Department of Health (DoH) and by two Federal Retail Pharmacy Partnership programs (Moderna-retail and Pfizer-retail) 26 . directly to corporations operating pharmacy chains in Pennsylvania [30] [31] [32] . Those corporations then determined which of their retail locations would receive vaccine shipments and how many doses those shipments would contain 33 . With these data, we were able to test three hypotheses associated with four basic questions concerning vaccine equity: H1: Were Whiter neighborhoods more likely to receive at least some vaccine shipments? H2: Did Whiter neighborhoods receive more doses when they received vaccine shipments? H3: Did White people tend to have more doses shipped to their neighborhoods overall? By separately analyzing the DoH, Moderna-retail, and Pfizer-retail datasets, we were able explore one additional question: H4: Did retail pharmacy chains allocate vaccine across their Pennsylvania stores locations in a way that was less equitable (with respect to H1, H2, and H3) than DoH allocations? In other words, we were able to explore whether public-private partnerships 34 -which made rapid development and production of COVID-19 vaccines possible 35,36 -might have had negative consequences for vaccine equity [37] [38] [39] . Such explorations may prove critical in determining how to equitably distribute the variant-specific boosters now being tested in humans 40, 41 . Table 1 provides demographic information for all neighborhoods, as well as separate demographics for areas that did and did not receive any of the 6,365,810 vaccine doses in our dataset. Neighborhoods receiving no vaccine during Phase 1 (n = 2,217) had an average of 32.8% more Black residents per capita (11.6%) than neighborhoods that did receive vaccine (8.8%). By contrast, we observed just 0.7% fewer adults under age 65 (who were ineligible to vaccinated at that time) in those neighborhoods (61.1% vs. 61.5%). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The odds of a neighborhood receiving any Pfizer-retail vaccine increased by 18.1% for every 1,000 White residents (OR = 1.18). Among neighborhoods receiving vaccine, an additional 599 doses could be expected per 1,000 White residents ( Figure 1a) . Additional residents who selfidentified on the Census as Hispanic or Latino or as members of other races had no significant effect on the expected odds of receiving any vaccine, nor did they have a significant effect on quantity of doses received ( Table 2 ). Neighborhoods with more White residents were more likely to receive any vaccine shipments, and such neighborhoods also tended to receive more vaccine doses in those shipments. Consequently, White people had an average of 102.3% more Pfizer-retail doses shipped to their neighborhoods (MDOSES = 39.7, SD = 0.09) than Black people did (MDOSES = 19.6, SD = 0.06). This difference was statistically significant (t = 3.45, p < .001). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Estimates represent change in log odds of neighborhoods (n = 3,218) receiving any COVID-19 vaccine for every 1,000 residents of each race. Other races and Hispanic/Latino/a/e/x populations included in initial logistic regression models but excluded by model-fitting and selection processes. A neighborhood's odds of receiving any vaccine via Moderna-retail partnerships increased by 15.0% for every 1,000 White residents (OR = 1.15) and by 25.1% (OR = 1.25) for every 1,000 Black residents. Neighborhoods receiving vaccine received an additional 134 additional doses for every 1,000 White residents, but only 51 doses per 1,000 Black residents (Table 3) . Additional residents of other races or ethnicities had no additional effect on either of these outcomes. Black population had a slightly stronger effect on the odds of a neighborhood receiving any Moderna-retail vaccine than White population did. However, White population had a much stronger effect than Black population on the quantity of doses shipped to such neighborhoods. As a result, the average White person in Pennsylvania had 60.3% more Moderna-retail doses (MDOSES = 93.1, SD = 0.07) shipped to their neighborhood than the average Black person did (MDOSES= 57.2, SD = 0.06). This difference was statistically significant (t = 6.38, p < .001). The odds of DoH shipping any vaccine to a neighborhood increased by 114.1% for every 1,000 White residents (OR = 1.14) but decreased by 13.3% for every 1,000 Black residents (OR = 0.76). Neighborhoods receiving DoH shipments-which were often intended for subsequent reallocation to multiple points of service 29 -could expect 1,475 doses per 1,000 White residents and 8,183 doses per 1,000 Black residents. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. DoH was more likely to send at least some vaccine to neighborhoods with larger White populations and less likely to go to neighborhoods with larger black populations. However, the number of doses sent to these neighborhoods (Figure 3c ) tended to decrease as White population increased. The net result of these effects was a 16.6% advantage in average number of neighborhood doses for White (MDOSES = 1913) and Black (MDOSES = 1641) Pennsylvanians, though this difference was not significant according to standard criteria (t = 1.19, p = .13). These findings support the view that Black-White racial disparities in COVID-19 vaccination rates during Phase 1 of Pennsylvania's vaccination plan reflect racial inequities in COVID-19 vaccine allocation. All three allocation programs provided greater neighborhood-level access to COVID-19 vaccines for White people than for Black people. Strikingly, these inequitable outcomes (H3) persisted across allocation programs, even though no two programs followed the same racialized pattern in both shipment of any vaccine (H1) and quantity of doses in those shipments (H2). Note that because Black and White populations were the only significant factors in our best-fitting regression models, we limit our discussion here to these two populations. Pfizer-retail was more likely to ship some vaccine to Whiter neighborhoods, and for all neighborhoods that did receive shipments, it sent more doses to Whiter neighborhoods. Consequently, White people (46.3) had an average of 135% more Phase 1 Pfizer-retail doses in their neighborhood than Black people did (19.6). Moderna-retail was actually more likely to ship some vaccine to neighborhoods with larger Black populations, but it shipped more doses to Whiter neighborhoods. The net effect of this was a 62.8% advantage in the average number of neighborhood-level doses this program provided White people (93.1) as compared to Black All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.12.22272300 doi: medRxiv preprint people (57.2). DoH did roughly the opposite of Moderna-retail, disproportionately sending at least some vaccine to Whiter neighborhoods but sending far fewer doses to neighborhoods with larger Black populations. Though the racial disparity in quantity of neighborhood-level doses was smallest for DoH, that program still conferred a 16.5% advantage to White Pennsylvanians (1931) over Black Pennsylvanians (1641). Collectively, these findings also suggest that public-private partnerships might produce more inequitable outcomes than state-run programs (H4). However, to determine whether this is generally the case, additional analyses of other states' data are needed. Still, in Pennsylvania the White advantage in vaccine access was greatest when corporations with retail locations, rather than state government, determined where to send vaccine. This discrepancy is most apparent when comparing the Pfizer-retail allocations to DoH allocations. Despite federal approval to ship vaccine to any of more than 1,000 pharmacy locations in Pennsylvania (and over 40,000 locations nationwide) 32 , Pfizer-retail sent 0 of its 127,530 Pennsylvania doses to neighborhoods with fewer than 28.9% White residents. The program completely overlooked the 269 least-White neighborhoods in the state. While the racial inequities in vaccine allocation we have identified are striking, we believe that they likely understate inequities in vaccine access. There are a number of factors that may compound the effects of vaccine allocation inequities in vaccine access inequities, and we have not attempted to study them here. In addition to having less neighborhood-level access to vaccine, Black Pennsylvanians may have been less able to obtain vaccine outside their own neighborhoods, given racial disparities in transportation access 43 , work commute time 44 , and internet access 45 . Even for those living in neighborhoods with ample vaccine supply, we might expect racial inequities in the opportunity to be vaccinated, given that White people were up to 40% more likely than Black people to be eligible for telework during the COVID-19 pandemic [46] [47] [48] . These are critical issues for policymakers to consider for future vaccine rollouts, and the failure to address them could have deadly consequences for people of all races. Even from a so-called "race-neutral" perspective 49, 50 , where the goal is to reduce overall harm to society as a whole 51 , the racial disparities we have identified cannot be justified. The Pennsylvania COVID-19 Task Force allocation of initial doses was intended to reflect "disease epidemiology and local community factors 9 ." So why send less vaccine to areas with more Black people, given that they tended to have more face-to-face interactions during the pandemic than White people did 52,53 ? Pennsylvania's Phase 1 sought to prioritize "critical populations 29 " for vaccination. So why make it harder for Black people-who were 21.9% more likely to be employed as frontline workers during the pandemic-to get vaccinated 54 ? Medical ethicists and epidemiologists recognize that there might always be tradeoffs between racial equity and overall utility 25, 55 , but the allocation patterns we observed appear to have thwarted both virtues. By the end of Phase One, approximately one in five doses allocated to Pennsylvania by the CDC had not been administered to anyone at all 16 . For all three vaccine allocation programs analyzed here, race had an outsized impact on where vaccine shipments went, how many doses those shipments contained, or both. That said, it would be premature to conclude that the inequitable vaccine distribution patterns we discovered in these All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.12.22272300 doi: medRxiv preprint data were the result of racial targeted discrimination. Perhaps other differences between neighborhoods that correlate with race, such as median income 56 , led corporations to allocate more vaccine to retail pharmacy locations whose patients were most likely to make purchases while in-store for their shots. For the much larger quantity of doses allocated by DoH, the geographic distribution of hospitals, pharmacies and other semi-permanent physical structures may have made it nearly inevitable that vaccine would be shipped to the Whitest neighborhoods. 57 We think that both explanations are quite plausible-not because we have analyzed any data to support them, but because we are aware of the persistent health effects of institutional and structural racism of this kind 8, 58, 59 . Future research should investigate the relationship between vaccine allocation, racial demography, and "third variables" like these. In the meantime, policies are urgently needed to increase oversight, transparency, and racial equity into the vaccine allocation process. As of this writing, new COVID-19 variants of concern have been emerging roughly once every six months 60, 61 . Pharmaceutical companies have proposed to manufacture and distribute new and improved COVID-19 vaccines as soon as this month 40, 41 . And a genuine commitment to vaccine equity-both within and beyond the U.S. 22is long overdue. The setting, location, time period, and data collection for this research were determined by the considerations described in the introduction. Our primary outcome measures were neighborhoods' status with respect to receiving any vaccine shipments (a binary variable) and total doses received (a continuous variable). All available data concerning the quantities and destinations of COVID-19 vaccine shipped to Pennsylvania through by DoH, Moderna-retail, and Pfizer-retail were downloaded from the Department of Health (DoH) website 42 , to which they had been posted by the state on a weekly basis. Our predictors were racial and ethnic population subtotals within neighborhoods (defined here as census tracts). Estimates of the racial and ethnic population totals in each of Pennsylvania's 3,218 census tracts were obtained from the 2015-2019 American Community Survey 5-Year Estimate Data Profiles 21, 63 . Since geodemographic data in the U.S. reflect historical and current practices of hypodescent ("the one-drop rule") 64 , we drew on estimates of populations All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.12.22272300 doi: medRxiv preprint identifying as "One race, [Race], not Hispanic or Latino," "Multiracial, not Hispanic or Latino," and "Hispanic or Latino." We recognize the critical limitations of this simplistic and nonexhaustive approach and discuss this elsewhere 65, 66 . After resolving formatting inconsistencies across public datasets, and between those datasets and USPS address standards, we identified each vaccine shipment with the census tract of its destination. To achieve this, all shipment addresses were uploaded to the Census Bureau's Geocoding Services Web Application Interface (API) for batched geographic identification. Addresses that were not initially geoidentified successfully were then mapped to their geographic coordinates (geocoded) via the Google Maps API. These coordinates were then uploaded to the Census Bureau's geocoding API for batched geographic identification. All addresses that remained unidentified due to absent or errant city or ZIP code data (0.28%) were manually assigned to the PA census tracts of identical street addresses elsewhere in our dataset. Dose quantities were missing for some Moderna-retail shipments during the first and third weeks of that program. These were imputed as 100 doses, which was both the modal and minimal allocation quantity for Moderna-retail shipments during that time. Because of heterogeneity between the three allocation programs and their data (concerning quantities shipped, time period of operation, and personnel involved), Moderna-retail, Pfizer-retail, and DoH allocations were analyzed separately for all inferential statistics. Descriptive statistics, which we include in order to provide a snapshot of the outcomes of these allocation programs from the perspective of Pennsylvania residents, are reported statewide rather than exclusively by allocation program. The allocation of any vaccine to a neighborhood depends on the prior availability of suitable vaccination sites and cold storage facilities. In contrast, the quantity of doses shipped to neighborhoods in which these are sites and facilities are available is somewhat more discretionary. Since the processes leading to these two outcomes are distinct (one taking place primarily pre-pandemic, the other during the pandemic), we ran three analyses for each of the three datasets. First, we ran logistic regressions to estimate the effects of racial and ethnic population subtotals on receipt of any vaccine. We selected the best-fitting models for each allocation program using the approach advocated by Hosmer and Lemeshow 67 , and their final selection was validated in all cases using the Akaike information criterion. Second, we conducted linear regressions to estimate the expected number of doses shipped to neighborhoods in each allocation program as a function of racial and ethnic population subtotals. Best-fitting models were selecting using the approach described in Cohen et al 68 . Third, we estimated the net impact of these two effects (on any doses and on quantity of doses, if any) to White and Black populations' relative opportunity to be vaccinated. For these estimates, we also report the average number of doses to which Black and White Pennsylvanians had neighborhood-level access. In line with existing research into geodemographic health All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Weighted variance was calculated with this same approach to provide standard deviations and facilitate reporting of population-weighted t-tests 71 . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.12.22272300 doi: medRxiv preprint COVID-19 vaccination hesitancy in Hispanics and African-Americans: A review and recommendations for practice Why are Black people being treated like America's vaccine hesitancy problem? The Philadelphia Inquirer Minority Communities, Doctors Are Changing Minds About Vaccination. The New York Times Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy Understanding Drivers of Coronavirus Disease 2019 Vaccine Hesitancy Among Blacks SNL slammed for stereotyping Black Americans and vaccine hesitancy Trustworthiness before Trust -Covid-19 Vaccine Trials and the Black Community Reckoning with histories of medical racism and violence in the USA Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present COVID-19 Vaccine Acceptance and Beliefs among Black and Hispanic Americans COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination -United States Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom COVID-19 Vaccination Demographic Trends by Report Date Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties -United States Changes in COVID-19 Vaccine Hesitancy Among Black and White Individuals in the US Percent of Total Population that has Received a COVID-19 Vaccine by Race/Ethnicity Food Access, Chronic Kidney Disease, and Hypertension in the U The Contextual Effect of the Local Food Environment on Residents' Diets: The Atherosclerosis Risk in Communities Study Separate and Unequal: Residential Segregation and Estimated Cancer Risks Associated with Ambient Air Toxics in U.S. Metropolitan Areas Understanding and Using American Community Survey Data: What All Data Users Need to Know An ethical framework for global vaccine allocation Constructing an ethical framework for priority allocation of pandemic vaccines Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines Evaluation of Vaccination Strategies to Compare Efficient and Equitable Vaccine Allocation by Race and Ethnicity Across Time COVID-19 Vaccine Distribution. PA Department of Health PA COVID-19 Vaccine Task Force. COVID-19 Interim Vaccination Plan V8.0. PA Department of Health How COVID-19 Vaccines Get to You Trump Administration Partners with Chain and Independent Community Pharmacies to Increase Access to Future COVID-19 Vaccines Initial Launch of the Federal Retail Pharmacy Program, and Expansion of FEMA Reimbursement to States The Federal Retail Pharmacy Program for COVID-19 Vaccination COVID-19 Retail Pharmacy Partners Vaccine Allocation Current Health. PA Department of Health Importance of Pharmacy Partnerships in Effective COVID-19 Vaccine Distribution Developing Safe and Effective Covid Vaccines -Operation Warp Speed's Strategy and Approach A strategic approach to COVID-19 vaccine R&D Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States Framework for Equitable Allocation of COVID-19 Vaccine Structural Racism in the COVID-19 Pandemic: Moving Forward Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster Candidate and Publication of Data on Booster Durability Against Omicron Variant Provide Update on Omicron Variant COVID-19 Vaccine Distribution. Pennsylvania Department of Health Geographic disparities in COVID-19 infections and deaths: The role of transportation All workers should have reasonable commutes. National Equity Atlas Inequities in Technology Contribute to Disparities in COVID-19 Vaccine Distribution Ability to work from home: evidence from two surveys and implications for the labor market in the COVID-19 pandemic Telework and Time Use in the United States Workers ages 25 to 54 more likely to telework due to COVID-19 in Color-blind racism in pandemic times US adults' preferences for race-based and place-based prioritisation for COVID-19 vaccines A. it lawful and ethical to prioritize racial minorities for COVID-19 Vaccines? Quantifying population contact patterns in the United States during the COVID-19 pandemic Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic Racial and ethnic differentials in COVID-19-related job exposures by occupational standing in the US Optimal influenza vaccine distribution with equity Neighborhood Economic Status, Income Inequality and Mortality Race/Ethnicity and Geographic Access to Urban Trauma Care Reckoning with histories of medical racism and violence in the USA Structural Racism and Health Inequities: Old Issues How Structural Racism Works -Racist Policies as a Root Cause of U.S. Racial Health Inequities Will SARS-CoV-2 variants of concern affect the promise of vaccines? Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Wolf Administration Expands Vaccination for Federal Pharmacy Partnership for Long-Term Care Facilities, Launches Retail Pharmacy Partnership The Devil and the One Drop Rule: Racial Categories, African Americans, and the U Racial and ethnic demographic data gaps in the U.S. and the erasure of racialized experiences: Lessons from the racial data tracker The Racial Data Gap: Lack of Racial Data as a Barrier to Overcoming Structural Racism Applied Logistic Regression Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences National Patterns in Environmental Injustice and Inequality: Outdoor NO2 Air Pollution in the United States Trends in Health Equity in the United States by Race/Ethnicity, Sex, and Income Weighted comparison of means No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity Acknowledgements: We thank Neda Khoshkhoo, Elaine Nsoesie, Yanique Redwood, and Caty Taborda for their valuable feedback on earlier drafts. We also thank Piranavakumar Kandaswamy for assisting with data validation and code management.